Study Summary
This trial tests a nurse-led intervention to help improve quality of life for people living with Alzheimer's and their caregivers, and to make them safer in the community.
- Alzheimer's Disease
- Mild Cognitive Impairment
Treatment Effectiveness
Effectiveness Progress
Study Objectives
18 Primary · 0 Secondary · Reporting Duration: at study completion, an average of 8 weeks
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
SUPPORT-D Group
1 of 1
Experimental Treatment
60 Total Participants · 1 Treatment Group
Primary Treatment: SUPPORT-D Group · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is there an ongoing opportunity to join this trial?
"As indicated on the clinicaltrials.gov platform, this medical trial is still recruiting patients and commenced in December of 2022; further updates were made to the study that same month." - Anonymous Online Contributor
What is the current tally of participants in this research endeavor?
"Affirmative, the details posted on clinicaltrials.gov indicate that this trial has begun recruiting participants. The initial posting was made December 1st 2022 and recently updated on the same day. 60 patients are required to be recruited from a single medical centre." - Anonymous Online Contributor